JOSEPH KOENIGSMARK: Open Payments
NPI 1437214731 · SHEPHERDSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 42 payments from 8 companies in 2025. Trend: 2023 $521 · 2024 $569 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $142 |
| Indivior Inc. | 8 | $126 |
| Orexo US, Inc. | 7 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Gilead Sciences, Inc. | 3 | $69 |
| Almatica Pharma LLC | 1 | $22 |
| Corium, LLC | 1 | $14 |
Products named: SUBLOCADE, Zubsolv, MAVYRET, CAPLYTA, REXULTI, VRAYLAR, LOREEV XR, Azstarys.
Industry payments across KY — which companies pay providers there.
